Patients requiring aortography frequently suffer from generalized arteriosclerosis. Uncontrolled hypotension is therefore clearly undesirable, especially if associated with myocardial depression. Significant hypotension was observed following the use of conventional ionic contrast media, Urografin 370 and Cardioconray, and occurred following every injection in this study. Metrizamide, a non-ionic contrast medium, was found to be associated with a smaller fall in blood pressure of a shorter duration.
Introduction
The injection of contrast media into the abdominal aorta results in a sensation of heat and pain in the lower limbs, a fall in blood pressure and increased blood flow within the legs (Delius & Erikson 1969 , Boijsen et al. 1971 . These effects are regarded as being related to the hyperosmolality of the contrast media (Lindgren 1970) . While vasodilatation is a factor in the development of hypotension, the fall in systolic blood pressure is also attributable to the deleterious direct effects that contrast media are known to have on the heart (Berg et al. 1973 , Stadalnik et al. 1974 . The patients who undergo aortography for lower limb ischaemia often have generalized arteriosclerosis and a limited cardiac reserve. Clearly, the effect of hypotension, if profound and prolonged, is likely to be deleterious in such patients. A range of contrast media with low osmolality have been developed in the last few years. One such substance is metrizamide (Amipaque), a non-ionic contrast medium which has been shown to produce less limb pain and less of an increase in blood flow within the legs on aortic injection than conventional hyperosmolar contrast agents (Almen et al. 1977) . The present study investigates the frequency and severity of hypotension resulting from the intra-aortic injection of two conventional ionic angiographic contrast media, Urografin 370 and Cardioconray, and the non-ionic agent metrizamide.
Method
The study was performed on 43 patients in whom either a catheter was inserted into the aorta, via the transfemoral approach using the Seldinger technique, or translumbar aortography was performed when femoral catheterization was not possible. Contrast medium (35 ml) was injected at a rate of 15-20 ml/sec. The contrast medium was injected into the lower part of the abdominal aorta in all cases, irrespective of the route of introduction, and was warmed to body temperature before injection.
The blood pressure of the 43 patients who underwent aortography was continuously monitored via the indwelling aortic cannula or needle. Twenty-seven patients received the conventional media (Urografin 370 or Cardioconray), the non-ionic metrizamide being used on 20 patients. A total of 83 injections of contrast medium were required in these cases.
The high incidence of severe pain following injections of Urografin 370 or Cardioconray necessitated general anaesthesia. However, local anaesthesia proved to be sufficient in 9 of the patients in the metrizamide group who did not have a general anaesthetic, the injection or contrast medium being painless and accompanied merely by a sensation of heat. There was no statistical difference when the changes of blood pressure measured after aortography with local anaesthesia were compared with those under general anaesthesia. General anaesthesia followed a standard procedure of induction with sodium thiopentone, relaxation provided by alcuronium, intubation and controlled ventilation; 60% nitrous oxide and 40% oxygen and 0.5% halothane were used to maintain anaesthesia. The fresh gas flow was adjusted to control the arterial carbon dioxide tension to low normal values (5-6 kPa). Local anaesthesia was provided by 20 ml of 1% lignocaine infiltrated around the femoral artery, sedation being induced by i.v. diazepam. The pressure recordings were obtained continuously by means of an Elcomatic strain gauge pressure transducer and monitor. Following its sterilization and calibration against a mercury manometer, the transducer was connected to the indwelling aortic cannula or needle. Heparinized saline was intermittently flushed through the cannula or needle to ensure an accurate and undamped recording. Frequent recordings of systolic and diastolic blood pressure were also made using an oscillotonometer. A close correlation was noted between the two methods of pressure measurement. Figure 1 ) A highly significant fall in both systolic (x 29 mmHg) and diastolic (x 19 mmHg) blood pressure was measured on every occasion following the injection of either Urografin 370 or Cardioconray. A smaller fall was noted with metrizamide, the systolic pressure falling significantly (x 10 mmHg) while the change in diastolic pressure was not statistically different. The duration of hypotension was significantly longer (P<0.0001) following conventional media (x 92 sec) than with metrizamide (x 42 sec).
Results (Table 1,

Discussion
The fall in blood pressure which results from the injection of conventional contrast media into the aorta has been found to occur within 20 or 30 seconds of injection and lasts for approximately 90 seconds (Delius & Erikson 1969 , Boijsen et al. 1971 ). This fall is more marked with increased concentration of iodine, with correspondingly increased hypertonicity of the contrast medium (Lindgren et al. 1968 ). An increased blood flow to the legs, due to vasodilatation, occurs simultaneously with the fall in blood pressure (Boijsen et al. 1971) .
Dimeric contrast media, which have a low osmolality, have been found to cause less pain and a smaller reduction in blood pressure than conventional hyperosmolar contrast media (Bjork et al. 1969 , Holm & Praestholm 1979 . The aortic injection of the non-ionic metrizaamide causes less pain and less increase in blood flow within the legs than a ). It has been found that metrizamide causes less depression of myocardial function on coronary arteriography than occurs with conventional contrast media such as the diatrizoates (Enge et al. 1977) . Previous reports on the hypotensive effects of intra-aortic contrast media have cited those with an iodine concentration of the order of 280 mg/ml. A recent trend has been routinely to employ contrast media, such as Urografin 370 (370 mgl/ml) and Cardioconray (400 mgl/ml), which have a much higher iodine content. Metrizamide, with an iodine concentration of 370 mgl/ml, has been found in the present study to cause a significantly smaller fall in blood pressure over a shorter period of time than these conventional hyperosmolar agents, yet has the same contrast density. Hypertensive patients have been shown to be particularly susceptible to a large fall in blood pressure following Urografin 370 or Cardioconray. It is concluded that metrizamide is to be preferred to conventional hyperosmolar contrast agents in hypertensive patients as well as those with hypovolaemia or cardiac disease who would be especially vulnerable to a substantial fall in blood pressure.
A recent survey (Macpherson et al. 1980 ) showed that aortography had been requested inappropriately by the clinician in more than a third of cases. A careful assessment of the need for aortography is required in view of the risks of the procedure and the expense of the newer, safer contrast agents.
